In the news: Promise of therapy
- Miracle cures and embryonic science. // Nature Biotechnology;Apr2001, Vol. 19 Issue 4, p287
Editorial. Focuses on the U.S. trial in which patients with a severe form of Parkinson's disease received human fetal nerve cell transplants. Side effects of trials; Need for evaluation of stem cell biology and its therapeutic potential before continuation of human testing of stem cells;...
- Rewiring the Parkinsonian brain. Fricker-Gates, Rosemary A.; Dunnett, Stephen B. // Nature Medicine;Feb2002, Vol. 8 Issue 2, p105
Focuses on the clinical application of embryonic stem cells in Parkinson disease (PD). Characteristics of PD; Suggestions made on the role of stem cells as an alternative source of dopamine cells for transplantation in PD patients.
- Now embryonic stem cells come without the risk of animal diseases. Nowak, Rachel // New Scientist;8/10/2002, Vol. 175 Issue 2355, p16
Reports the possibility of growing human embryonic stem cells free of animal diseases. Use of the stem cells to replace the dead nerve cells in patients with Parkinson's disease; Combination of the cells with cells from mouse fetuses and cow serum to grow them; Replacement of mouse cells and...
- Journal of Clinical Investigation: Generating dopamine via cell therapy for Parkinson's disease. // Biomedical Market Newsletter;7/19/2012, Vol. 21, p1
The article informs that replacement of dopaminergic neurons by neural transplantation with mouse embryonic stem cells is used in treatment of Parkinson's disease.
- Welcome to Stem Cell Research & Therapy. Donnelly, Ann; Johar, Surayya; O'Brien, Timothy; Tuan, Rocky S. // Stem Cell Research & Therapy;2010, Vol. 1 Issue 1, p1
An introduction is presented in which the editor discusses various topics within the inaugural issue of the journal including stem cell research, stem cell therapy and legislation affecting stem cell research and therapy, particularly embryonic stem cells.
- Stem Cell -- Tough Sell on Wall Street? O'Connell, Brian // BioPharm International;Dec2006, Vol. 19 Issue 12, p20
The article discusses issues about adult and embryonic stem cells. According to the author, embryonic stem cells are not the cure for Parkinson's disease as there is no scientific evidence which shows the technology to fight the disease effectively. On the other hand, adult stem cells have...
- Stem cell bank opens. // R&D Magazine;Nov2005, Vol. 47 Issue 11, p29
This article reports on the opening of the World Stem Cell Hub (WSCH) in South Korea in mid-October 2005. Within 24 hours, WSCH was overwhelmed with 9,500 applications from individuals seeking treatment from incurable diseases. WSCH is the world's first facility to store embryonic stem cells...
- Cells Show Promise for Parkinson's. // Technology Review;Jul2008, Vol. 111 Issue 4, p92
The article presents a study that assesses the capabilities of brain cells developed from skin cells to alleviate the symptoms and pain in Parkinson's disease. Rudolf Jaenish and colleagues administered the study by transforming mouse skin cells into undifferential cells induced into four...
- Long-term clinical outcomes after fetal cell transplantation in parkinson disease: implications for the future of cell therapy. Bega, Danny; Krainc, Dimitri // JAMA: Journal of the American Medical Association;2/12/2014, Vol. 311 Issue 6, p617
IMPORTANCE: Recent advances in stem cell technologies have rekindled an interest in the use of cell replacement strategies for patients with Parkinson disease. This study reports the very long-term clinical outcomes of fetal cell transplantation in 2 patients with Parkinson disease. Such...